The FDA announced on June 10, 2022, that Macleods Pharma USA Inc voluntarily recalled Losartan potassium & Hydrochlorothiazide Tablets due to azido impurity levels exceeding acceptable limits. The recall affects specific lots distributed nationwide.
How to tell if you have it
- Brand: Macleods Pharma
- Product: Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg
- NDC # 33342-052-07, NDC #33342-052-10 & NDC # 33342-052-44
- Lot # BLM2114A
- Expiration date: 07/2023
- Manufacturer: Macleods Pharma USA, Inc. Plainsboro, NJ 08536
The hazard
The recall was initiated because current Good Manufacturing Practice (CGMP) deviations resulted in azido impurity levels observed to be above acceptable limits. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Macleods Pharma USA, INC has 20 other recalls on record since 2015-12-24. Other recent recalls of similar products include Macleods Levothyroxine Tablets Recall (2026-02-26), Macleods Losartan/HCTZ Recall (2024-05-07), and Macleods Pharma Levofloxacin Tablets Recall (2023-01-05). Additional recent recalls include Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall (2026-01-21), Macleods Olanzapine Tablets 5mg Recall (2026-08-27), and Ajanta Pharma Fluphenazine Tablets Recall (2026-08-25).